July 2019

Financial toxicity, ACO contracts, removing barriers to care.

Selected abstracts from the 2019 Annual Meeting of the American Society of Clinical Oncology.

Research on biosimilars presented at the 2019 Annual Meeting of the American Society of Clinical Oncology.

From the Oncology Care Model to the possibilities of cannabis, policy issues drew big crowds at the 2019 Annual Meeting of the American Society of Clinical Oncology.

Cytokine release syndrome represents a major concern, and source of costs, associated with the life-saving gene therapy.

Real-world evidence is being embraced by FDA as a way to expand the review of data beyond the trial population, which may not be representative of the patients seen in clinics on a daily basis.

Clinical findings presented at the 2019 Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois.